Goldberg SN - Search Results

1

Innovations and challenges in renal cancer: consensus statement from the first international conference.

Atkins MB, Avigan DE, Bukowski RM, Childs RW, Dutcher JP, Eisen TG, Figlin RA, Finke JH, Flanigan RC, George DJ, Goldberg SN, Gordon MS, Iliopoulos O, Kaelin WG Jr, Linehan WM, Lipton A, Motzer RJ, Novick AC, Stadler WM, Teh BT, Yang JC, King L. Atkins MB, et al. Among authors: goldberg sn. Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6277S-81S. doi: 10.1158/1078-0432.CCR-040720. Clin Cancer Res. 2004. PMID: 15448017 Review. No abstract available.

2

Review of radiofrequency ablation for renal cell carcinoma.

Hines-Peralta A, Goldberg SN. Hines-Peralta A, et al. Among authors: goldberg sn. Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6328S-34S. doi: 10.1158/1078-0432.CCR-050004. Clin Cancer Res. 2004. PMID: 15448026

3

Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice.

Hakimé A, Hines-Peralta A, Peddi H, Atkins MB, Sukhatme VP, Signoretti S, Regan M, Goldberg SN. Hakimé A, et al. Among authors: goldberg sn. Radiology. 2007 Aug;244(2):464-70. doi: 10.1148/radiol.2442061005. Radiology. 2007. PMID: 17641366

4

Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy.

Sabir A, Schor-Bardach R, Wilcox CJ, Rahmanuddin S, Atkins MB, Kruskal JB, Signoretti S, Raptopoulos VD, Goldberg SN. Sabir A, et al. Among authors: goldberg sn. AJR Am J Roentgenol. 2008 Jul;191(1):133-9. doi: 10.2214/AJR.07.2848. AJR Am J Roentgenol. 2008. PMID: 18562736

5

Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?

Schor-Bardach R, Alsop DC, Pedrosa I, Solazzo SA, Wang X, Marquis RP, Atkins MB, Regan M, Signoretti S, Lenkinski RE, Goldberg SN. Schor-Bardach R, et al. Among authors: goldberg sn. Radiology. 2009 Jun;251(3):731-42. doi: 10.1148/radiol.2521081059. Radiology. 2009. PMID: 19474376 Free PMC article.

6

Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signaling.

Bhatt RS, Wang X, Zhang L, Collins MP, Signoretti S, Alsop DC, Goldberg SN, Atkins MB, Mier JW. Bhatt RS, et al. Among authors: goldberg sn. Mol Cancer Ther. 2010 Oct;9(10):2793-802. doi: 10.1158/1535-7163.MCT-10-0477. Epub 2010 Aug 10. Mol Cancer Ther. 2010. PMID: 20699227 Free PMC article.

7

Resistance of renal cell carcinoma to sorafenib is mediated by potentially reversible gene expression.

Zhang L, Bhasin M, Schor-Bardach R, Wang X, Collins MP, Panka D, Putheti P, Signoretti S, Alsop DC, Libermann T, Atkins MB, Mier JW, Goldberg SN, Bhatt RS. Zhang L, et al. Among authors: goldberg sn. PLoS One. 2011 Apr 29;6(4):e19144. doi: 10.1371/journal.pone.0019144. PLoS One. 2011. PMID: 21559452 Free PMC article.

8

High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma.

Wang X, Zhang L, Goldberg SN, Bhasin M, Brown V, Alsop DC, Signoretti S, Mier JW, Atkins MB, Bhatt RS. Wang X, et al. Among authors: goldberg sn. J Transl Med. 2011 Dec 21;9:220. doi: 10.1186/1479-5876-9-220. J Transl Med. 2011. PMID: 22188900 Free PMC article.

9

Radio frequency ablation of renal cell carcinoma via image guided needle electrodes.

McGovern FJ, Wood BJ, Goldberg SN, Mueller PR. McGovern FJ, et al. Among authors: goldberg sn. J Urol. 1999 Feb;161(2):599-600. J Urol. 1999. PMID: 9915457 No abstract available.

10

Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation.

Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Goldberg SN, et al. Cancer. 2000 Jun 1;88(11):2452-63. Cancer. 2000. PMID: 10861420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

313 results

Search Page